NCT05838209

Brief Summary

The goal of this clinical trial is to evaluate the use of ozone oil as an adjunctive of non-surgical periodontal treatment (NSPT) on diabetics type 2 patients (DM2) compared to control group with chronic periodontal disease. The principal question is to evaluate if the ozone oil could improve periodontal clinical parameters. Thirty-two sites of 16 diabetics type 2 patients (DM2) with moderate to advanced periodontal disease containing two sites with periodontal pocket depth (PPD) of \> 5 mm were selected. The treatment was distributed in 2 groups in the split mouth design: Control- scaling and root planing + saline solution (control) and Test - scaling and root planning + ozone oil

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

April 5, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

May 1, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

June 7, 2023

Status Verified

June 1, 2023

Enrollment Period

2 months

First QC Date

April 5, 2023

Last Update Submit

June 5, 2023

Conditions

Keywords

Periodontitis, Periodontal treatment, diabetes

Outcome Measures

Primary Outcomes (4)

  • Plaque Index

    Percentage

    baseline

  • Gingival Index

    Percentage

    baseline

  • Probing Depth

    mm

    baseline

  • clinical attachment level

    mm

    baseline

Secondary Outcomes (4)

  • Plaque Index

    3 months

  • Gingival Index

    3 months

  • Probing Depth

    3 months

  • clinical attachment levels

    3 months

Study Arms (2)

Control

PLACEBO COMPARATOR

Scaling and root planing + saline solution gel (control) will be adminster at probing depth \> 5mm.

Drug: Control

Test

ACTIVE COMPARATOR

Scaling and root planing + Ozone Oil will be adminster at probing depth \> 5mm.

Drug: test

Interventions

testDRUG

Ozone oil used as an adjunctive of scaling and root planing and control,

Test

saline solution 0.09% used as an adjunctive as scaling and root planing

Also known as: Placebo Control
Control

Eligibility Criteria

Age18 Years - 70 Years
Sexall(Gender-based eligibility)
Gender Eligibility Detailspatients over 18 years old
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Periodontitis
  • Systemic type 2 diabetes

You may not qualify if:

  • Hypersensitivity to ozone oil
  • Osteoporosis types I and II
  • Alcoholism
  • Immunosuppressio
  • Pregnant and lactating
  • Physical/emotional stress drugs
  • Use of antibiotics, anti-inflammatories and hormone
  • Oral candidiasis
  • Received periodontal treatment in the last six months prior to the procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gabriela Alessandra da Cruz Galhardo Camargo

Nova Friburgo, Rio de Janeiro, 28625650, Brazil

RECRUITING

Related Publications (1)

  • Mauri-Obradors E, Merlos A, Estrugo-Devesa A, Jane-Salas E, Lopez-Lopez J, Vinas M. Benefits of non-surgical periodontal treatment in patients with type 2 diabetes mellitus and chronic periodontitis: A randomized controlled trial. J Clin Periodontol. 2018 Mar;45(3):345-353. doi: 10.1111/jcpe.12858. Epub 2018 Jan 19.

    PMID: 29265454BACKGROUND

MeSH Terms

Conditions

Periodontal DiseasesPeriodontitisDiabetes Mellitus

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Participants - The randomization performed will use the coin heads or tails method, Investigators -Two treatments at randomly chosen sites separate in two groups: Ozone oil use as an adjunctive of scaling and root planing and saline solution 0.09%, as a control, associate as an adjunctive of scaling and root planing. Ultrasonic scaler and Gracey curets use to remove all calculus and biofilms during scaling and root planing. The oils are numbere syringes labeled 1 and 2 for blinded applications, and 1 ml of each oil were administrated in a previous selected site. After removing baseline samples of biofilm, the scaling and root planing were performed using ultrasonic devices and manual Gracey curettes.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a prospective clinical randomized controlled, split mouth designed, doble blinded study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

April 5, 2023

First Posted

May 1, 2023

Study Start

April 5, 2023

Primary Completion

June 1, 2023

Study Completion

July 1, 2023

Last Updated

June 7, 2023

Record last verified: 2023-06

Locations